Skip to main content

Alto Neuroscience

Los Altos, United States

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

$120.0M raised
Mar 2026
Post Ipo Equity

Top Investors

Franklin TempletonGaingelsValor Equity PartnersPerceptive AdvisorsVivo Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Alto Neuroscience

How much funding has Alto Neuroscience raised?
Alto Neuroscience has raised $120.0M in total funding. The most recent round was Post Ipo Equity. The last funding was announced in March 2026.
Who are Alto Neuroscience's investors?
Alto Neuroscience's investors include Franklin Templeton, Gaingels, Valor Equity Partners, Perceptive Advisors, Vivo Capital.
Where is Alto Neuroscience headquartered?
Alto Neuroscience is headquartered in Los Altos, United States.
What does Alto Neuroscience do?
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
What stage is Alto Neuroscience at?
Alto Neuroscience is at the Post Ipo Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Alto Neuroscience — Funding & Investors." VCBacked, March 16, 2026, https://www.vcbacked.co/company/alto-neuroscience. Accessed June 4, 2026.
APA
VCBacked. (2026). Alto Neuroscience — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/alto-neuroscience
Wikipedia (cite web)
{{cite web |title=Alto Neuroscience — Funding & Investors |url=https://www.vcbacked.co/company/alto-neuroscience |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .